Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,683
Closed -$255K 3538
2025
Q1
$255K Sell
6,683
-1,242
-16% -$52.7K ﹤0.01% 2784
2024
Q4
$348K Buy
7,925
+1,142
+17% +$50.2K ﹤0.01% 2500
2024
Q3
$292K Buy
6,783
+546
+9% +$24.3K ﹤0.01% 2591
2024
Q2
$282K Sell
6,237
-259
-4% -$13.4K ﹤0.01% 2505
2024
Q1
$406K Buy
6,496
+759
+13% +$45.4K ﹤0.01% 2201
2023
Q4
$321K Sell
5,737
-408
-7% -$20.3K ﹤0.01% 2272
2023
Q3
$324K Buy
6,145
+1,609
+35% +$93.8K ﹤0.01% 2090
2023
Q2
$291K Buy
4,536
+46
+1% +$2.62K ﹤0.01% 2143
2023
Q1
$240K Buy
+4,490
New +$260K ﹤0.01% 2249
2022
Q2
Sell
-9,416
Closed -$645K 1392
2022
Q1
$645K Buy
+9,416
New +$671K ﹤0.01% 1056
2016
Q2
Sell
-15,754
Closed -$775K 554
2016
Q1
$775K Buy
+15,754
New +$670K 0.05% 265

Other funds holding ENOV

Mariner's ENOV Position: Q2 2025 in Review

Mariner sold out of Enovis (ENOV) in Q2 2025, closing a stake of 6,683 shares — an estimated $255K sold.

Mariner first reported a position in ENOV in Q1 2016 and held it in 11 quarters. The position peaked at $775K in Q1 2016. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • Mariner reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • Mariner sold 6,683 Enovis shares in Q2 2025, an estimated $255K.
  • Mariner first reported a position in Enovis in Q1 2016 and held it in 11 quarters.
  • Mariner's Enovis position peaked at $775K in Q1 2016.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.